Aprea Therapeutics (APRE) Amortization of Deferred Charges (2021 - 2022)
Aprea Therapeutics (APRE) posted quarterly Amortization of Deferred Charges of $61247.0 for Q3 2022, down 7.63% year-over-year from $66307.0 in Q3 2021, and up 2.13% quarter-over-quarter from $59970.0 in Q2 2022.
Aprea Therapeutics (APRE) Amortization of Deferred Charges (2021 - 2022) Analysis & Trends
Aprea Therapeutics (APRE) has reported Amortization of Deferred Charges for 2 consecutive years, with $61247.0 the latest figure, recorded in Q3 2022.
- In Q3 2022, Amortization of Deferred Charges fell 7.63% year-over-year to $61247.0; the TTM figure through Dec 2022 stood at $182042.0 (down 29.67% YoY), while the FY2022 annual figure was $182042.0, down 29.67% from the prior year.
- Amortization of Deferred Charges rose to $61247.0 in Q3 2022 per APRE's latest filing, from $59970.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $72416.0 in Q1 2021 and bottomed at $57102.0 in Q2 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Aprea Therapeutics | 34.25 Mn | 34.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 61,247.00 |
| Sep 30, 2022 | 61,247.00 |
| Jun 30, 2022 | 59,970.00 |
| Jun 30, 2022 | 59,970.00 |
| Mar 31, 2022 | 60,825.00 |
| Mar 31, 2022 | 60,825.00 |
| Dec 31, 2021 | 63,023.00 |
| Dec 31, 2021 | 63,023.00 |
| Sep 30, 2021 | 66,307.00 |
| Sep 30, 2021 | 66,307.00 |
| Jun 30, 2021 | 57,102.00 |
| Jun 30, 2021 | 57,102.00 |
| Mar 31, 2021 | 72,416.00 |
| Mar 31, 2021 | 72,416.00 |